Orphan designation: Nirogacestat Treatment of soft tissue sarcoma, 17/10/2019 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 8 April 2024 - 15:14

Orphan designation: Nirogacestat Treatment of soft tissue sarcoma, 17/10/2019 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-19-2214

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters